[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH PTEN; BAI1 AND GRIN2B.
TISSUE=Mammary gland;
DOI=10.1074/jbc.M909741199; PubMed=10748157 [NCBI, ExPASy, EBI, Israel, Japan]
Wu Y.,
Dowbenko D.,
Spencer S.,
Laura R.,
Lee J.,
Gu Q.,
Lasky L.A.;
"Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.";
J. Biol. Chem. 275:21477-21485(2000).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
DOI=10.1016/j.yexcr.2004.10.007; PubMed=15652357 [NCBI, ExPASy, EBI, Israel, Japan]
Franklin J.L.,
Yoshiura K.,
Dempsey P.J.,
Bogatcheva G.,
Jeyakumar L.,
Meise K.S.,
Pearsall R.S.,
Threadgill D.,
Coffey R.J.;
"Identification of MAGI-3 as a transforming growth factor-alpha tail binding protein.";
Exp. Cell Res. 303:457-470(2005).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04727; PubMed=16710414 [NCBI, ExPASy, EBI, Israel, Japan]
Gregory S.G.,
Barlow K.F.,
McLay K.E.,
Kaul R.,
Swarbreck D.,
Dunham A.,
Scott C.E.,
Howe K.L.,
Woodfine K.,
Spencer C.C.A.,
Jones M.C.,
Gillson C.,
Searle S.,
Zhou Y.,
Kokocinski F.,
McDonald L.,
Evans R.,
Phillips K.,
Atkinson A., ![]()
Cooper R.,
Jones C.,
Hall R.E.,
Andrews T.D.,
Lloyd C.,
Ainscough R.,
Almeida J.P.,
Ambrose K.D.,
Anderson F.,
Andrew R.W.,
Ashwell R.I.S.,
Aubin K.,
Babbage A.K.,
Bagguley C.L.,
Bailey J.,
Beasley H.,
Bethel G.,
Bird C.P.,
Bray-Allen S.,
Brown J.Y.,
Brown A.J.,
Buckley D.,
Burton J.,
Bye J.,
Carder C.,
Chapman J.C.,
Clark S.Y.,
Clarke G.,
Clee C.,
Cobley V.,
Collier R.E.,
Corby N.,
Coville G.J.,
Davies J.,
Deadman R.,
Dunn M.,
Earthrowl M.,
Ellington A.G.,
Errington H.,
Frankish A.,
Frankland J.,
French L.,
Garner P.,
Garnett J.,
Gay L.,
Ghori M.R.J.,
Gibson R.,
Gilby L.M.,
Gillett W.,
Glithero R.J.,
Grafham D.V.,
Griffiths C.,
Griffiths-Jones S.,
Grocock R.,
Hammond S.,
Harrison E.S.I.,
Hart E.,
Haugen E.,
Heath P.D.,
Holmes S.,
Holt K.,
Howden P.J.,
Hunt A.R.,
Hunt S.E.,
Hunter G.,
Isherwood J.,
James R.,
Johnson C.,
Johnson D.,
Joy A.,
Kay M.,
Kershaw J.K.,
Kibukawa M.,
Kimberley A.M.,
King A.,
Knights A.J.,
Lad H.,
Laird G.,
Lawlor S.,
Leongamornlert D.A.,
Lloyd D.M.,
Loveland J.,
Lovell J.,
Lush M.J.,
Lyne R.,
Martin S.,
Mashreghi-Mohammadi M.,
Matthews L.,
Matthews N.S.W.,
McLaren S.,
Milne S.,
Mistry S.,
Moore M.J.F.,
Nickerson T.,
O'Dell C.N.,
Oliver K.,
Palmeiri A.,
Palmer S.A.,
Parker A.,
Patel D.,
Pearce A.V.,
Peck A.I.,
Pelan S.,
Phelps K.,
Phillimore B.J.,
Plumb R.,
Rajan J.,
Raymond C.,
Rouse G.,
Saenphimmachak C.,
Sehra H.K.,
Sheridan E.,
Shownkeen R.,
Sims S.,
Skuce C.D.,
Smith M.,
Steward C.,
Subramanian S.,
Sycamore N.,
Tracey A.,
Tromans A.,
Van Helmond Z.,
Wall M.,
Wallis J.M.,
White S.,
Whitehead S.L.,
Wilkinson J.E.,
Willey D.L.,
Williams H.,
Wilming L.,
Wray P.W.,
Wu Z.,
Coulson A.,
Vaudin M.,
Sulston J.E.,
Durbin R.M.,
Hubbard T.,
Wooster R.,
Dunham I.,
Carter N.P.,
McVean G.,
Ross M.T.,
Harrow J.,
Olson M.V.,
Beck S.,
Rogers J.,
Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J.,
Istrail S.,
Sutton G.G.,
Florea L.,
Halpern A.L.,
Mobarry C.M.,
Lippert R.,
Walenz B.,
Shatkay H.,
Dew I.,
Miller J.R.,
Flanigan M.J.,
Edwards N.J.,
Bolanos R.,
Fasulo D.,
Halldorsson B.V.,
Hannenhalli S.,
Turner R.,
Yooseph S., ![]()
Lu F.,
Nusskern D.R.,
Shue B.C.,
Zheng X.H.,
Zhong F.,
Delcher A.L.,
Huson D.H.,
Kravitz S.A.,
Mouchard L.,
Reinert K.,
Remington K.A.,
Clark A.G.,
Waterman M.S.,
Eichler E.E.,
Adams M.D.,
Hunkapiller M.W.,
Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 252-1506 (ISOFORM 2).
TISSUE=Brain;
DOI=10.1093/dnares/7.4.271; PubMed=10997877 [NCBI, ExPASy, EBI, Israel, Japan]
Nagase T.,
Kikuno R.,
Nakayama M.,
Hirosawa M.,
Ohara O.;
"Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.";
DNA Res. 7:273-281(2000).
|
[7]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 953-1506 (ISOFORM 1).
TISSUE=Ileal mucosa;
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T.,
Suzuki Y.,
Nishikawa T.,
Otsuki T.,
Sugiyama T.,
Irie R.,
Wakamatsu A.,
Hayashi K.,
Sato H.,
Nagai K.,
Kimura K.,
Makita H.,
Sekine M.,
Obayashi M.,
Nishi T.,
Shibahara T.,
Tanaka T.,
Ishii S.,
Yamamoto J., ![]()
Saito K.,
Kawai Y.,
Isono Y.,
Nakamura Y.,
Nagahari K.,
Murakami K.,
Yasuda T.,
Iwayanagi T.,
Wagatsuma M.,
Shiratori A.,
Sudo H.,
Hosoiri T.,
Kaku Y.,
Kodaira H.,
Kondo H.,
Sugawara M.,
Takahashi M.,
Kanda K.,
Yokoi T.,
Furuya T.,
Kikkawa E.,
Omura Y.,
Abe K.,
Kamihara K.,
Katsuta N.,
Sato K.,
Tanikawa M.,
Yamazaki M.,
Ninomiya K.,
Ishibashi T.,
Yamashita H.,
Murakawa K.,
Fujimori K.,
Tanai H.,
Kimata M.,
Watanabe M.,
Hiraoka S.,
Chiba Y.,
Ishida S.,
Ono Y.,
Takiguchi S.,
Watanabe S.,
Yosida M.,
Hotuta T.,
Kusano J.,
Kanehori K.,
Takahashi-Fujii A.,
Hara H.,
Tanase T.-O.,
Nomura Y.,
Togiya S.,
Komai F.,
Hara R.,
Takeuchi K.,
Arita M.,
Imose N.,
Musashino K.,
Yuuki H.,
Oshima A.,
Sasaki N.,
Aotsuka S.,
Yoshikawa Y.,
Matsunawa H.,
Ichihara T.,
Shiohata N.,
Sano S.,
Moriya S.,
Momiyama H.,
Satoh N.,
Takami S.,
Terashima Y.,
Suzuki O.,
Nakagawa S.,
Senoh A.,
Mizoguchi H.,
Goto Y.,
Shimizu F.,
Wakebe H.,
Hishigaki H.,
Watanabe T.,
Sugiyama A.,
Takemoto M.,
Kawakami B.,
Yamazaki M.,
Watanabe K.,
Kumagai A.,
Itakura S.,
Fukuzumi Y.,
Fujimori Y.,
Komiyama M.,
Tashiro H.,
Tanigami A.,
Fujiwara T.,
Ono T.,
Yamada K.,
Fujii Y.,
Ozaki K.,
Hirao M.,
Ohmori Y.,
Kawabata A.,
Hikiji T.,
Kobatake N.,
Inagaki H.,
Ikema Y.,
Okamoto S.,
Okitani R.,
Kawakami T.,
Noguchi S.,
Itoh T.,
Shigeta K.,
Senba T.,
Matsumura K.,
Nakajima Y.,
Mizuno T.,
Morinaga M.,
Sasaki M.,
Togashi T.,
Oyama M.,
Hata H.,
Watanabe M.,
Komatsu T.,
Mizushima-Sugano J.,
Satoh T.,
Shirai Y.,
Takahashi Y.,
Nakagawa K.,
Okumura K.,
Nagase T.,
Nomura N.,
Kikuchi H.,
Masuho Y.,
Yamashita R.,
Nakai K.,
Yada T.,
Nakamura Y.,
Ohara O.,
Isogai T.,
Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
|
[8]
|
SUBCELLULAR LOCATION.
DOI=10.1006/excr.2002.5475; PubMed=11969287 [NCBI, ExPASy, EBI, Israel, Japan]
Laura R.P.,
Ross S.,
Koeppen H.,
Lasky L.A.;
"MAGI-1: a widely expressed, alternatively spliced tight junction protein.";
Exp. Cell Res. 275:155-170(2002).
|
[9]
|
INTERACTION WITH HPV E6, AND PROBABLE UBIQUITINATION.
DOI=10.1038/sj.onc.1205668; PubMed=12140759 [NCBI, ExPASy, EBI, Israel, Japan]
Thomas M.,
Laura R.,
Hepner K.,
Guccione E.,
Sawyers C.,
Lasky L.,
Banks L.;
"Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.";
Oncogene 21:5088-5096(2002).
|
[10]
|
INTERACTION WITH HPV E6.
DOI=10.1128/JVI.78.22.12366-12377.2004; PubMed=15507623 [NCBI, ExPASy, EBI, Israel, Japan]
Lee C.,
Laimins L.A.;
"Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.";
J. Virol. 78:12366-12377(2004).
|
[11]
|
INTERACTION WITH HPV E6.
DOI=10.1038/sj.onc.1207977; PubMed=15378012 [NCBI, ExPASy, EBI, Israel, Japan]
Massimi P.,
Gammoh N.,
Thomas M.,
Banks L.;
"HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation.";
Oncogene 23:8033-8039(2004).
|
[12]
|
INTERACTION WITH HTLV TAX1.
DOI=10.1016/j.virol.2003.11.014; PubMed=15003862 [NCBI, ExPASy, EBI, Israel, Japan]
Ohashi M.,
Sakurai M.,
Higuchi M.,
Mori N.,
Fukushi M.,
Oie M.,
Coffey R.J.,
Yoshiura K.,
Tanaka Y.,
Uchiyama M.,
Hatanaka M.,
Fujii M.;
"Human T-cell leukemia virus type 1 Tax oncoprotein induces and interacts with a multi-PDZ domain protein, MAGI-3.";
Virology 320:52-62(2004).
|
[13]
|
LIGANDS THAT BIND AND INHIBIT PDZ DOMAINS.
DOI=10.1016/j.bmcl.2006.10.006; PubMed=17055267 [NCBI, ExPASy, EBI, Israel, Japan]
Fujii N.,
Haresco J.J.,
Novak K.A.,
Gage R.M.,
Pedemonte N.,
Stokoe D.,
Kuntz I.D.,
Guy R.K.;
"Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions.";
Bioorg. Med. Chem. Lett. 17:549-552(2007).
|
[14]
|
INTERACTION WITH LPAR2.
DOI=10.1016/j.cellsig.2006.06.008; PubMed=16904289 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang H.,
Wang D.,
Sun H.,
Hall R.A.,
Yun C.C.;
"MAGI-3 regulates LPA-induced activation of Erk and RhoA.";
Cell. Signal. 19:261-268(2007).
|
[15]
|
INTERACTION WITH HPV E6, AND PROBABLE UBIQUITINATION.
DOI=10.1038/sj.onc.1210810; PubMed=17934525 [NCBI, ExPASy, EBI, Israel, Japan]
Massimi P.,
Shai A.,
Lambert P.,
Banks L.;
"HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.";
Oncogene 27:1800-1804(2008).
|
|
ExPASy Home page
